Drug intelligence / Profile preview

Befact Piano

Development stage: Unknown
Lead developer: SMB Laboratoires
Modality: Small Molecules
Administration: Oral

Overview

Befact Piano is an oral vitamin B complex dietary supplement developed and marketed by Laboratoires SMB in Belgium. It is formulated as an over-the-counter (OTC) consumer product containing a combination of B vitamins, specifically B1 (thiamine), B2 (riboflavin), B6 (pyridoxine), and B12 (cobalamin). The supplement is designed to support energy metabolism, normal nervous system and heart function, and psychological health, while helping to reduce tiredness and fatigue. Unlike Befact Forte, which is a medicinal product intended for the treatment of severe vitamin B deficiencies, Befact Piano is classified as a nutritional supplement for general health support and maintenance of energy levels.

Brand names: Befact Piano
Other names: Befact

Beyond the preview

Go deeper on Befact Piano.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Befact Piano.

Explore the full profile